首页> 外国专利> New 1-sulfonyl-2-oxo-dihydroindole derivatives are selective antagonists of vasopressin receptors useful e.g. for treating hypertension, cardiac insufficiency, unstable angina or affective disorders

New 1-sulfonyl-2-oxo-dihydroindole derivatives are selective antagonists of vasopressin receptors useful e.g. for treating hypertension, cardiac insufficiency, unstable angina or affective disorders

机译:新的1-磺酰基-2-氧代-二氢吲哚衍生物是血管加压素受体的选择性拮抗剂,可用于例如抗氧化剂。用于治疗高血压,心脏功能不全,不稳定型心绞痛或情感障碍

摘要

1-sulfonyl-2-oxo-2,3-dihydroindole derivatives (I) and their tautomers, enantiomers and/or diastereomers, prodrugs and salts are new. 1-sulfonyl-2-oxo-2,3-dihydroindole derivatives of formula (I) and their tautomers, enantiomers and/or diastereomers, prodrugs and salts are new. A : 6-10C aryl (optionally substituted); B : (partially) aromatic 6-10C mono- or bi-cyclic residue (optionally substituted); R 1H, 1-6C alkyl, OH, 1-4C alkoxy, di(1-4C alkyl)amino, CN, carbamoyl, trifluoromethoxy, trifluoromethyl, bromo, fluoro, chloro, iodo, nitro, formamido, 1-4C alkylcarbonylamino or ureido; R 2H, 1-4C alkyl, 1-4C alkoxy, chloro or fluoro; R 3W-X-Y-Z; W : 1-4C alkylene, (0-4C alkylene)-O-(0-4C alkylene) or (0-4C alkylene)-NR 15-(0-4C alkylene); R 15H or 1-4C alkyl; X : CO, SO 2, C=NH or C=N-CN; Y : e.g. pyrrolidindiyl, piperazindiyl or piperidindiyl (optionally substituted); and Z : e.g. pyrrolidinyl, azepinyl or morpholino. The full definitions are given in the DEFINITIONS (Full Definitions) field. An independent claim is also included for two methods for preparing (I). [Image] ACTIVITY : Uropathic; Antithrombotic; Anticoagulant; Hypotensive; Cardiant; Antianginal; Antiischemic; Nephrotropic; Antiinflammatory; Antidiuretic; Hepatotropic; Antiulcer; Antiemetic; Antidepressant; Tranquilizer; Nootropic; Neuroprotective. MECHANISM OF ACTION : Vasopressin receptor antagonist, e.g. V 1a and V 1b receptor antagonist. N-(1-(2,4-dimethoxybenzenesulfonyl-5-chloro-2-oxo-3-(2-methoxyphenyl)-2,3-dihydro-1H-indol-3-yl) 4-(1-methylpiperidin-4-yl)-piperazine-1-carboxamide dihydrochloride (Ia) had affinity constant for the V 1a receptor below 100 nM, when tested by the method of Br. J. Pharmacol., 125 (1998) 1463.
机译:1-磺酰基-2-氧代-2,3-二氢吲哚衍生物(I)及其互变异构体,对映异构体和/或非对映异构体,前药和盐是新的。式(I)的1-磺酰基-2-氧代-2,3-二氢吲哚衍生物及其互变异构体,对映异构体和/或非对映异构体,前药和盐是新的。 A:6-10C芳基(任选取代); B :(部分)芳族6-10C单环或双环残基(可选取代); R 1> H,1-6C烷基,OH,1-4C烷氧基,二(1-4C烷基)氨基,CN,氨基甲酰基,三氟甲氧基,三氟甲基,溴,氟,氯,碘,硝基,甲酰胺基,1-4C烷基羰基氨基或ureido; R 2> H,1-4C烷基,1-4C烷氧基,氯或氟; R 3> W-X-Y-Z; W:1-4C亚烷基,(0-4C亚烷基)-O-(0-4C亚烷基)或(0-4C亚烷基)-NR 15>-(0-4C亚烷基); R 15> H或1-4C烷基; X:CO,SO 2,C = NH或C = N-CN; Y:例如吡咯烷基二基,哌嗪二基或哌啶二基(可选取代);和Z:例如吡咯烷基,a庚基或吗啉代。完整定义在“定义(完整定义)”字段中给出。对于两种制备方法(I)也包括独立权利要求。活动:空灵;抗血栓抗凝物;降压;卡迪恩抗心绞痛抗缺血嗜肾消炎(药;抗利尿剂肝抗溃疡;止吐药;抗抑郁药镇静剂;促智;具有神经保护作用。作用机理:加压素受体拮抗剂,例如V 1a和V 1b受体拮抗剂。 N-(1-(2,4-二甲氧基苯磺酰基-5-氯-2-氧-3-(2-甲氧基苯基)-2,3-二氢-1H-吲哚-3-基)4-(1-甲基哌啶-4当通过Br.J.Pharmacol。,125(1998)1463的方法测试时,β-基)-哌嗪-1-羧酰胺二盐酸盐(Ia)对V 1a受体的亲和常数低于100 nM。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号